{
    "body": "The CXCR2 receptor is targeted in cancer. Name five antagonists.", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/15623601", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19549892", 
        "http://www.ncbi.nlm.nih.gov/pubmed/15805273", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22590561", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21328342", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19809428", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17634442", 
        "http://www.ncbi.nlm.nih.gov/pubmed/18289803", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20967859", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23204236", 
        "http://www.ncbi.nlm.nih.gov/pubmed/11700073", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20652010", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23019013", 
        "http://www.ncbi.nlm.nih.gov/pubmed/16540656", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21670971", 
        "http://www.ncbi.nlm.nih.gov/pubmed/18790747", 
        "http://www.ncbi.nlm.nih.gov/pubmed/18780829", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22391039", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23359652", 
        "http://www.ncbi.nlm.nih.gov/pubmed/12244149", 
        "http://www.ncbi.nlm.nih.gov/pubmed/12753603", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19293256", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21035946"
    ], 
    "ideal_answer": [
        "There are numerous CXCR2 receptor antagonists, such as SB225002, G31P, SCH-527123, AZ10397767, SCH-479833."
    ], 
    "exact_answer": [
        [
            "SB225002"
        ], 
        [
            "G31P"
        ], 
        [
            "SCH-527123"
        ], 
        [
            "AZ10397767"
        ], 
        [
            "SCH-479833"
        ]
    ], 
    "concepts": [
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0048019", 
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0006605", 
        "http://www.uniprot.org/uniprot/CXCR2_HUMAN", 
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0045238", 
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0046817", 
        "http://www.disease-ontology.org/api/metadata/DOID:162"
    ], 
    "type": "list", 
    "id": "5141bcd423fec9037500000d", 
    "snippets": [
        {
            "offsetInBeginSection": 517, 
            "offsetInEndSection": 559, 
            "text": "CXCR2 small-molecule antagonist (SB225002)", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23204236", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 121, 
            "text": "G31P, an antagonist against CXC chemokine receptors 1 and 2, inhibits growth of human prostate cancer cells in nude mice.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23019013", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 58, 
            "text": "The CXCR2 antagonist, SCH-527123, shows antitumor activity", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22391039", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 761, 
            "offsetInEndSection": 809, 
            "text": "retreatment with the CXCR2 antagonist AZ10397767", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18790747", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 477, 
            "offsetInEndSection": 690, 
            "text": "The aim of this study was to investigate whether the CXCR2 antagonist, SCH-527123, inhibits colorectal cancer proliferation and if it can sensitize colorectal cancer cells to oxaliplatin both in vitro and in vivo.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22391039", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 196, 
            "offsetInEndSection": 441, 
            "text": "we report that targeting CXCR2 and CXCR1 activity using orally active small molecule antagonist (SCH-527123, SCH-479833) inhibits human colon cancer liver metastasis mediated by decreased neovascularization and enhanced malignant cell apoptosis.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21035946", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 593, 
            "offsetInEndSection": 720, 
            "text": "CXCR2-specific small molecule inhibitor (AZ10397767) to investigate the recruitment and function of human neutrophils in tumors", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21328342", 
            "endSection": "sections.0"
        }
    ]
}